PLEASE SELECT THE DESTINATION COUNTRY AND LANGUAGE :
KANZEN R&D
Kanzen's R&D network verified with differentiated core technology and research results
Kanzen R&D Network
The Kanzen R&D Research Center of Kanzen,
a global bio company, is the starting point of Kanzen Cosmedical and studies
safer and more reliable next-generation core technologies.
Through continuous research on botulinum toxin,
we developed TBT-A1 technology using CDP technology
to provide only high-quality products which have been proven medically.
With differentiated botulinum raw materials and a different level of skin care technology,
we lead the true cosmedical market Through the development of raw materials,
quality control, and better technology.
R&D Center
View of Seoul National University's
Biotechnology Research Building
Inside the Headquarters Research Center
(3rd floor of the Biotechnology Research Building)
Co - Partner
ABL3
Animal Lab
Veterinary Science
Research Center
Next-generation immunotherapy Basic development
Bioinformatics
Research Center
Kanzen Network
Seven types of botulinum toxin isolated from
domestic soil are unique strains isolated with Kanzen's proprietary technology,
and they are the competitiveness in making differentiated products.
Research to secure the largest number of botulinum strains in the world is ongoing.
Copyright © 2022 kanzencosmedical. All rights reserved.
02-876-4633
kanzencosmedical@kanzen.co.kr
PLEASE SELECT THE DESTINATION COUNTRY AND LANGUAGE :
